Source link : https://newshealth.biz/health-news/benralizumab-cuts-hypereosinophilic-syndrome-flares/
(MedPage Today) — ORLANDO — Anti-interleukin (IL)-5 receptor alpha monoclonal antibody benralizumab (Fasenra) reduced flares in hypereosinophilic syndrome (HES), the phase III NATRON trial showed. Once-monthly injections reduced risk of a… Source link : https://www.medpagetoday.com/meetingcoverage/acaai/118393 Author : Publish date : 2025-11-09 13:17:00 Copyright for syndicated content belongs to the linked Source.
The post Benralizumab Cuts Hypereosinophilic Syndrome Flares first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-09 13:17:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8